CL2019001938A1 - Composiciones probióticas y usos de las mismas. - Google Patents

Composiciones probióticas y usos de las mismas.

Info

Publication number
CL2019001938A1
CL2019001938A1 CL2019001938A CL2019001938A CL2019001938A1 CL 2019001938 A1 CL2019001938 A1 CL 2019001938A1 CL 2019001938 A CL2019001938 A CL 2019001938A CL 2019001938 A CL2019001938 A CL 2019001938A CL 2019001938 A1 CL2019001938 A1 CL 2019001938A1
Authority
CL
Chile
Prior art keywords
lactobacillus
prevention
probiotic compositions
treatment
combination
Prior art date
Application number
CL2019001938A
Other languages
English (en)
Spanish (es)
Inventor
Daniel Agardh
Ahrén Irini Lazou
Lars Niklas Larsson
Original Assignee
Probi Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1700542.2A external-priority patent/GB201700542D0/en
Priority claimed from GBGB1709731.2A external-priority patent/GB201709731D0/en
Application filed by Probi Ab filed Critical Probi Ab
Publication of CL2019001938A1 publication Critical patent/CL2019001938A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
CL2019001938A 2017-01-12 2019-07-11 Composiciones probióticas y usos de las mismas. CL2019001938A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1700542.2A GB201700542D0 (en) 2017-01-12 2017-01-12 Probiotic compositions and uses thereof
GBGB1709731.2A GB201709731D0 (en) 2017-06-19 2017-06-19 Probiotic compositions and uses thereof

Publications (1)

Publication Number Publication Date
CL2019001938A1 true CL2019001938A1 (es) 2019-09-27

Family

ID=61386800

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2019001938A CL2019001938A1 (es) 2017-01-12 2019-07-11 Composiciones probióticas y usos de las mismas.

Country Status (13)

Country Link
US (1) US11166993B2 (enExample)
EP (1) EP3568144B1 (enExample)
JP (1) JP7089523B2 (enExample)
KR (1) KR102500496B1 (enExample)
CN (1) CN110177561B (enExample)
AU (1) AU2018207946B2 (enExample)
CA (1) CA3049624A1 (enExample)
CL (1) CL2019001938A1 (enExample)
MX (1) MX2019008292A (enExample)
MY (1) MY195253A (enExample)
PH (1) PH12019501629A1 (enExample)
RU (1) RU2763311C2 (enExample)
WO (1) WO2018130667A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112584848A (zh) * 2018-06-18 2021-03-30 普罗比公司 益生菌组合物及其用途
IT201900014550A1 (it) * 2019-08-09 2021-02-09 Abiogen Pharma Spa Uso di colecalciferolo come agente attivo nel trattamento della celiachia
CN116869141A (zh) * 2022-05-05 2023-10-13 内蒙古一康健康发展有限责任公司 一种具有保健功能的益生菌复合物及其制备方法
KR102845919B1 (ko) * 2023-02-28 2025-08-14 주식회사 피엘비앤비 장내 유해세균의 성장 억제 성능이 우수한 한국인 모유 유래 락티카제이바실러스 파라카제이 pl1536 및 이를 유효성분으로 포함하는 기능성식품 조성물
CN119279210A (zh) * 2024-12-16 2025-01-10 山东健源生物科技有限公司 一种复合益生菌发酵含药食同源物质的多谷物后生元制剂及其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004076615A2 (en) * 2003-02-27 2004-09-10 Bioneer A/S Immunomodulating probiotic compounds
WO2006097949A1 (en) * 2005-03-16 2006-09-21 Actial Farmacêutica, Lda. Mixture of at least 6 species of lactic acid bacteria and/or bifidobacteria in the manufacture of sourdough
ZA200802934B (en) * 2005-10-06 2009-09-30 Probi Ab Use of lactobacillus for treatment of virus infections
KR101300086B1 (ko) * 2005-10-06 2013-08-30 프로비 아베 자가면역질환의 치료를 위한 락토바실러스의 용도
WO2007108763A1 (en) 2006-03-17 2007-09-27 Probac Ab Use of lactobacillus strains for promoting immunotolerance in autoimmune disease
US8137952B2 (en) 2006-03-17 2012-03-20 Probac Ab Thermostable lactobacillus strains
EP3269379A1 (en) 2008-11-30 2018-01-17 Immusant, Inc. Compositions and methods for treatment of celiac disease
EP2581461B1 (en) * 2011-10-14 2014-09-24 GenMont Biotech Incorporation Composition and use of lactobacillus paracasei strain GMNL-133 in treating atopic dermatitis or other allergic diseases
MX363899B (es) 2012-06-18 2019-04-05 Heinz Co Brands H J Llc Trastornos relacionados con gluten.
KR102129934B1 (ko) * 2013-04-03 2020-07-03 프로비 아베 골다공증의 치료 또는 예방에 사용되는 프로바이오틱 스트레인
WO2016083450A2 (en) * 2014-11-25 2016-06-02 Stichting Top Institute Food And Nutrition New probiotic and new biomarker

Also Published As

Publication number Publication date
CN110177561A (zh) 2019-08-27
BR112019014418A2 (pt) 2020-04-14
US20190358275A1 (en) 2019-11-28
EP3568144A1 (en) 2019-11-20
PH12019501629A1 (en) 2020-06-01
WO2018130667A1 (en) 2018-07-19
JP7089523B2 (ja) 2022-06-22
AU2018207946A1 (en) 2019-07-25
US11166993B2 (en) 2021-11-09
AU2018207946B2 (en) 2024-07-18
RU2019121145A3 (enExample) 2021-04-26
RU2019121145A (ru) 2021-02-12
KR102500496B1 (ko) 2023-02-16
JP2020513780A (ja) 2020-05-21
CA3049624A1 (en) 2018-07-19
CN110177561B (zh) 2023-09-12
EP3568144B1 (en) 2024-05-08
RU2763311C2 (ru) 2021-12-28
EP3568144C0 (en) 2024-05-08
KR20190104568A (ko) 2019-09-10
MX2019008292A (es) 2019-09-16
MY195253A (en) 2023-01-11

Similar Documents

Publication Publication Date Title
BR112015025256A8 (pt) Cepas probióticas para uso no tratamento ou prevenção da osteoporose
EA202091389A1 (ru) Композиция на основе пробиотиков и её применение
AR106768A1 (es) Composiciones que comprenden cepas bacterianas
CL2012000869A1 (es) Composicion que comprende cepa seleccionada de lactobacillus plantarum cect 7527, o cepas mutantes de la misma; uso de una composicion para prevenir y/o tratar transtornos cardiovasculares.
CO2019000099A2 (es) Composiciones que comprenden cepas bacterianas
MX395076B (es) COMPOSICIÓN A BASE DE UN EXTRACTO DE BIOACTIVO DE L. fermentum PARA USARSE EN EL TRATAMIENTO DE CONDICIONES DERMATOLOGICAS HUMANAS.
BR112021025676A2 (pt) Composições e métodos para tratar uma afecção mediada por th2 com o uso de prevotella
CL2018001936A1 (es) Nueva cepa bacteriana probiótica de lactobacillus plantarum y composiciones y usos de la misma en el tratamiento de la inflamación.
BR112018003123A2 (en) composition, enema, isolated strain, method for treating and / or preventing a gastrointestinal condition, and use of an isolated bacterial composition, enema or one or more isolated strains
PH12019501629A1 (en) Probiotic compositions and uses therof
AR107921A1 (es) Uso de probióticos en el tratamiento y/o la prevención de la enfermedad de la psoriasis
MX2017016283A (es) Lactobacillus paracasei para la produccion de acido linoleico conjugado, preparaciones nutricionales y farmaceuticas que lo contienen y sus usos.
MX2020013439A (es) Composiciones probioticas y usos de las mismas.
MX2018004616A (es) Cosmetica qie tiene bacterias probioticas.
BR112017023636A2 (pt) suplemento dietético
MX392754B (es) Seleccion de cepas bacterianas utiles en el tratamiento de la alergia.
BR112019001919A2 (pt) composição de tratamento de superfícies rígidas, método para fornecer o brilho da superfície e utilização da composição
CL2017001706A1 (es) Empleo de probióticos en el incremento de la fertilidad masculina.
MX2024006254A (es) Uso de postbioticos en el tratamiento y/o prevencion de los trastornos de ansiedad.
CO2024015660A2 (es) Composiciones probióticas para el tratamiento de la alopecia
BR112021020617A2 (pt) Composições probióticas e usos das mesmas
MX392976B (es) Composiciones que comprenden cepas bacterianas.
BR112018070518A2 (pt) bactéria do gênero bifidobacterium, usos de uma bactéria do gênero bifidobacterium e método para reduzir a ingestão de alimentos, energia e/ou gordura
CO2018001271A2 (es) Composición microbiana de microorganismos probióticos
CO2020009424A2 (es) Composición que comprende nuevas cepas de lactobacillus salivarius y método para la prevención y el tratamiento de otitis e infecciones respiratorias de vías altas